Clinical Trial Update: Renal Function Optimization With Mycophenolate Mofetil (MMF) Immunosuppressor Regimes (ALHAMBRA) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating mycophenolate mofetil–based immunosuppressive regimens to optimize renal function in kidney transplant patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Kidney Transplant Rejection

Drugs mentioned

• MYCOPHENOLATE MOFETIL (MYCOPHENOLATE MOFETIL)

Snippet

Sponsor: Sociedad Andaluza de Trasplantes de Organos y Tejidos | Conditions: Kidney Diseases, Graft Rejection | Phase 4 | Status: UNKNOWN